Not affiliated with the Pennsylvania General Assembly · an independent reference by Fifty Domes

PlansSign in

Bills › 2025–2026 Regular Session › State Senate bill

SB 8652025–2026
bill

2025–2026 Regular Session · State Senate bill

SB 865

An Act amending Title 35 (Health and Safety) of the Pennsylvania Consolidated Statutes, in miscellaneous provisions, further providing for urine drug screening requirement and providing for medetomidine awareness education.

In committee Last action October 7, 2026: Re-referred to Appropriations

Official bill page and text: palegis.us

Sponsors 3

Prime sponsor
Michele Brooks
Cosponsors (2)
Christine Tartaglione, Doug Mastriano

Status

In committee as of October 7, 2026. Session ends November 30, 2026; the 2027–2028 session begins in January 2027.

Roll-call votes 1

October 6, 2026State SenateCommittee vote (Health & Human Services): Reported as CommittedPassed13–0

yes (13) Amanda Cappelletti, Art Haywood, Daniel Laughlin, Frank Farry, Judith Schwank, Judy Ward, Kim Ward, Lynda Schlegel Culver, Maria Collett, Michele Brooks, Patrick Stefano, Scott Hutchinson, Sharif Street

Official roll call

Timeline 5

DateChamberAction
October 7, 2026SenateRe-referred to Appropriations
October 7, 2026SenateSecond consideration
October 6, 2026SenateFirst consideration
October 6, 2026SenateReported as committed
June 18, 2025SenateReferred to Health & Human Services

Data: Open States (API v3; public data, attribution appreciated), updated November 5, 2026. Official record: palegis.us. Bill pages link to the official text, not copied.

Sources for this page

Bill, action and roll-call data from Open States (public data, attribution appreciated). Neither Pennsylvania Capitol Guide nor this information, as presented here, is endorsed by the Pennsylvania General Assembly.